Irfan Ali-Khan

Title: Irfan Ali-Khan: Innovator in Molecular Probes for Cancer Diagnosis

Introduction

Irfan Ali-Khan is a notable inventor based in Saratoga, California. He has made significant contributions to the field of molecular diagnostics, particularly in the development of innovative probes for cancer detection and treatment.

Latest Patents

Irfan Ali-Khan holds a patent for "Self-quenching activatable COX-2-specific multi-modal molecular probes for diagnosis of cancers, inflammation, and immune system disorders." This invention encompasses pharmaceutically acceptable compositions formulated for the topical or transdermal delivery of probes specific for cyclooxygenase-2 (COX-2) in both human and non-human subjects. The activatable probe features a fluorescent moiety with a fluorophore attached to a compound that selectively binds to COX-2, along with a removable fluorescence quencher linked by a cleavable linker. Upon delivery, the probe is localized in tissues with elevated COX-2 levels, and the linker is cleaved to release the quencher, allowing for detectable fluorescent emission upon irradiation.

Career Highlights

Irfan Ali-Khan is affiliated with Leland Stanford Junior University, where he continues to advance research in molecular diagnostics. His work has the potential to significantly impact the diagnosis and treatment of various diseases, including cancer.

Collaborations

Irfan collaborates with esteemed colleagues such as Jayakumar Rajadas and Emilio Gonzalez, contributing to a dynamic research environment focused on innovative solutions in healthcare.

Conclusion

Irfan Ali-Khan's work exemplifies the intersection of innovation and healthcare, showcasing how targeted molecular probes can enhance diagnostic capabilities. His contributions are paving the way for advancements in the diagnosis and treatment of critical health conditions.